The private organization has provided scientific publications, online webinars, and packaging standards for a variety of GLP-1 agonists, including semaglutide (Ozempic/Wegovy), liraglutide (Saxenda), and exenatide (Byetta)
Injection site reactions occurred in 1015% of participants, slightly more than with semaglutide alone
Sustainable results still depend mainly on healthy eating, regular physical activity, long-term lifestyle changes and following medical treatment, if needed
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Diabetes Endocrinol
Semaglutide, a GLP-1 receptor agonist, works through a different biological pathway than thyroid hormones and does not interfere with thyroid medication absorption or effectiveness